Inverse agonists of H1-receptors as promising antiallergy agents (a review)

Pharmaceutical Chemistry Journal

Volumn 44, Issue 1, 2010, Pages 1-6

  Gushchin, I S ^a  

^a INSTITUTE OF IMMUNOLOGY   (Russian Federation)

Author keywords

antiallergic effect; H1 receptors; inverse agonists; NF B; second generation H1 antihistamine drugs

Indexed keywords

ACRIVASTINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; DESLORATADINE; EBASTINE; HISTAMINE H1 RECEPTOR AGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEVOCETIRIZINE; LORATADINE; TERFENADINE;

ALLERGY; ATOPY; BINDING AFFINITY; DRUG DESIGN; DRUG INDICATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; INFLAMMATION; LIGAND BINDING; MOLECULAR BIOLOGY; REVIEW;

EID: 77952301777     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-010-0386-9     Document Type: Review

References (40)

1. I. S. Gushchin, Allergic Inflammation and its Pharmacological Control [in Russian], Farmarus Print, Moscow (1998).
2. I. S. Gushchin, Ter. Arkh., No. 10, 27 - 34 (1997).
3. I. S. Gushchin, Antihistamine Drugs as Histamine Releasers and Inhibitors of its Release, in: Pathogenesis of Allergic Processes in Experiments and the Clinic [in Russian], Meditsina, Moscow (1979), pp. 118 - 131.
4. IS Gushchin AI Zebrev VG Chitaeva, et al. 1987 Khim.-farm. Zh. 21 1313 1317 1:CAS:528:DyaL1cXhtVKju7c%3D
5. I. S. Gushchin, Klin. Farmakol. Ter., No. 3, 82 - 86 (1998).
6. B Lebrun-Vignes B Diquet O Chosidow, et al. 2001 Clin. Pharmacokinet. 40 501 507 10.2165/00003088-200140070-00002 1:CAS:528:DC%2BD3MXms1ars74%3D 11510627
7. S Fantin J Maspero C Bisbal, et al. 2008 Allergy 63 924 931 10.1111/j.1398-9995.2008.01668.x 1:CAS:528:DC%2BD1cXovFSnsLs%3D 18588560
8. C Bachert P Kuna F Sanquer, et al. 2009 Allergy 64 158 165 10.1111/j.1398-9995.2008.01813.x 1:CAS:528:DC%2BD1MXitl2qur8%3D 19132976
9. FW Fraunfelder 2004 Drugs Today 40 677 683 10.1358/dot.2004.40.8.850470 1:CAS:528:DC%2BD2cXptV2nu7c%3D 15510239
10. MB Abelson 2004 Expert Opin. Pharmacother. 5 1979 1994 10.1517/14656566.5.9.1979 1:CAS:528:DC%2BD2cXmvFSmsb0%3D 15330735
11. J Mullol J Bousquet C Bachert, et al. 2008 Allergy 63 87 5 28 10.1111/j.1398-9995.2008.01640.x 18339040
12. F. E. R. Simons, ed., Histamine and H 1 -Receptor Antagonists in Allergic Disease, Marcel Dekker, Inc., New York (1996).
13. U Gether 2000 Endocr. Rev. 21 90 113 10.1210/er.21.1.90 1:CAS:528:DC%2BD3cXhs12hu7w%3D 10696571
14. M Le Coniat E Traifford M Ruat, et al. 1994 Hum. Genet. 94 186 188 10.1007/BF00202867 8045566
15. B Kuhn A Schmid C Harteneck, et al. 1996 Mol. Endocrinol. 10 1697 1707 10.1210/me.10.12.1697 1:STN:280:DyaK2s7itVKjtQ%3D%3D 8961278
16. RA Bakker SBJ Schoonus MJ Smit, et al. 2001 Mol. Pharmacol. 60 1133 1142 1:CAS:528:DC%2BD3MXnvVeksb4%3D 11641442
17. M Karin 1999 Oncogene 18 6867 6874 10.1038/sj.onc.1203219 1:CAS:528:DyaK1MXotVyhtLo%3D 10602462
18. O Hu S Deshpande K Irani, et al. 1999 J. Biol. Chem. 274 33995 33998 10.1074/jbc.274.48.33995 1:CAS:528:DyaK1MXnslOlurY%3D 10567364
19. LA Hart VL Krishnan IM Adcock, et al. 1998 Am. J. Respir. Crit. Care Med. 158 1585 1592 1:STN:280:DyaK1M%2FjsVOntQ%3D%3D 9817712
20. C Desmet P Gosset B Pajak, et al. 2004 J. Immunol. 173 5766 5775 1:CAS:528:DC%2BD2cXos1GhsLg%3D 15494529
21. ME Poynter R Cloots T Van Woerkom 2004 J. Immunol. 173 7003 7009 1:CAS:528:DC%2BD2cXhtVShsbrO 15557197
22. MC Catley JE Chivers NS Holden, et al. 2005 Br. J. Pharmacol. 145 114 122 10.1038/sj.bjp.0706170 1:CAS:528:DC%2BD2MXjsl2nu7g%3D 15723090
23. EL Bakkouri A Wullaert M Haegman, et al. 2005 J. Biol. Chem. 280 17938 17944 10.1074/jbc.M413588200 15722346
24. HJ Na PD Moon SG Ko, et al. 2005 J. Pharmacol. Sci. (Tokyo, Jpn) 97 219 226 10.1254/jphs.FP0040326 1:CAS:528:DC%2BD2MXhvFKlsbc%3D
25. Y Peng MR Power B Li TJ Lin 2005 J. Leukocyte Biol. 77 975 983 10.1189/jlb.0204115 1:CAS:528:DC%2BD2MXltValurs%3D 15784689
26. G Caramori IM Adcock K Ito 2004 Curr. Opin. Invest. Drugs 5 1141 1147 1:CAS:528:DC%2BD2cXhtFWqtrnN
27. J Buddenkotte C Stroh IH Engels, et al. 2005 J. Invest. Dermatol. 124 38 45 10.1111/j.0022-202X.2004.23539.x 1:CAS:528:DC%2BD2MXnvFClsA%3D%3D 15654951
28. K Asano KI Kanai H Suzaki 2004 Clin. Exp. Allergy 34 1890 1898 10.1111/j.1365-2222.2004.02127.x 1:CAS:528:DC%2BD2MXot1SntQ%3D%3D 15663564
29. MR Edwards N Mukaida M Johnson SL Johnston 2005 Pulm. Pharmacol. Ther. 18 337 345 10.1016/j.pupt.2004.12.015 1:CAS:528:DC%2BD2MXltVaqs7o%3D 15939312
30. 1 -Receptor Antagonists in Allergic Disease, F. E. R. Simons, ed., Marcel Dekker, Inc., New York (1996), pp. 33 - 60.
31. M Bruysters A Jongejan M Gillard, et al. 2005 Mol. Pharmacol. 67 1045 1052 10.1124/mol.104.008847 1:CAS:528:DC%2BD2MXjtFWmsr0%3D 15626750
32. M Church 2004 J. World Allergy Organization 16 112 116 10.1027/0838-1925.16.3.112
33. R Leurs MK Church M Taglialatela 2002 Clin. Exp. Allergy 32 489 498 10.1046/j.0954-7894.2002.01314.x 1:CAS:528:DC%2BD38XktlSiurc%3D 11972592
34. RA Bakker K Wieland H Timmerman R Leurs 2000 Eur. J. Pharmacol. 387 5 7 10.1016/S0014-2999(99)00803-1
35. M Govoni RA Bakker I van de Wetering, et al. 2003 J. Med. Chem. 46 5812 5824 10.1021/jm030936t 1:CAS:528:DC%2BD3sXptV2gu7o%3D 14667234
36. I. S. Gushchin, Ross. Allergol. Zh., No. 2, 3 - 14 (2006).
37. M Gillard M Strolin Benedetti P Chatelain E Baltes 2005 Inflammation Res. 54 367 369 10.1007/s00011-005-1368-3 1:CAS:528:DC%2BD2MXhtFOntL3K
38. A del Cuvillo J Millol J Bartra, et al. 2006 J. Invest. Allergol. Clin. Immunol. 16 1 3 12
39. JO Warner 2001 J. Allergy Clin. Immunol. 108 929 937 10.1067/mai.2001. 120015 1:CAS:528:DC%2BD38XltVOhtw%3D%3D 11742270
40. FER Simons 2007 Pediatr. Allergy Immunol. 18 535 542 10.1111/j.1399-3038. 2007.00558.x 17561929